Targeting ATR/CHK1 pathway in acute myeloid leukemia to overcome chemoresistance

Resistance of acute myeloid leukemia to current therapies leads to frequent relapses. Identification of molecular mechanisms involved in chemoresistance constitutes a key challenge to define new therapeutic concepts. Here, we show that the ATR/CHK1 pathway, essential in maintaining genomic stability...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Cell Oncol
Autors principals: David, Laure, Manenti, Stéphane, Récher, Christian, Hoffmann, Jean-Sébastien, Didier, Christine
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2017
Matèries:
Author's View
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5644474/
https://ncbi.nlm.nih.gov/pubmed/29057300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2017.1289293
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars